Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation
Novel, rationally-designed acrylate analogs of various known dipeptide substrates were found to be mechanism-based inactivators of the enzyme peptidylglycine alpha-amidating monooxygenase (PAM, EC 1.14.17.3). This enzyme is responsible for the rate-limiting and final bioactivation step, a C-termina...
Main Author: | |
---|---|
Published: |
Georgia Institute of Technology
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1853/31816 |
id |
ndltd-GATECH-oai-smartech.gatech.edu-1853-31816 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-GATECH-oai-smartech.gatech.edu-1853-318162013-01-07T20:35:09ZDesign, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidationFoster, Michael ScottMolecular modelingStereochemistryMolecules ModelsPeptidesChemical structurePeptide hormonesNeuropeptidesNovel, rationally-designed acrylate analogs of various known dipeptide substrates were found to be mechanism-based inactivators of the enzyme peptidylglycine alpha-amidating monooxygenase (PAM, EC 1.14.17.3). This enzyme is responsible for the rate-limiting and final bioactivation step, a C-terminal amidation of glycine-extended peptides, of a variety of peptide hormones including the potent pro-inflammatory compound Substance P. Protein-ligand docking studies, in tandem with in vitro kinetic analysis of these inactivators, indicated that the rational design of this class of compounds was successful in creating potent competitive inactivators of this enzyme. Pharmacological evaluation, via both acute and chronic models of inflammation in Sprague-Dawley rats, of these compounds indicates that they are highly potent anti-inflammatory agents which ameliorate both acute carrageenan-induced edema and the deleterious effects of chronic adjuvant-induced polyarthritis. Furthermore, these compounds were also able to induce a return toward a more normal phenotype in cancerous WB-Ras epithelial cells, via the interruption of the growth factor-stimulated pathway precipitated by Substance P. Finally, our modeling studies provide a structural basis for both the reaction and subsite stereospecificity of PAM toward its substrates, competitive inhibitors, and mechanism-based inactivators.Georgia Institute of Technology2010-01-29T19:55:26Z2010-01-29T19:55:26Z2008-11-18Dissertationhttp://hdl.handle.net/1853/31816 |
collection |
NDLTD |
sources |
NDLTD |
topic |
Molecular modeling Stereochemistry Molecules Models Peptides Chemical structure Peptide hormones Neuropeptides |
spellingShingle |
Molecular modeling Stereochemistry Molecules Models Peptides Chemical structure Peptide hormones Neuropeptides Foster, Michael Scott Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
description |
Novel, rationally-designed acrylate analogs of various known dipeptide substrates were found to be mechanism-based inactivators of the enzyme peptidylglycine alpha-amidating monooxygenase (PAM, EC 1.14.17.3). This enzyme is responsible for the rate-limiting and final bioactivation step, a C-terminal amidation of glycine-extended peptides, of a variety of peptide hormones including the potent pro-inflammatory compound Substance P. Protein-ligand docking studies, in tandem with in vitro kinetic analysis of these inactivators, indicated that the rational design of this class of compounds was successful in creating potent competitive inactivators of this enzyme. Pharmacological evaluation, via both acute and chronic models of inflammation in Sprague-Dawley rats, of these compounds indicates that they are highly potent anti-inflammatory agents which ameliorate both acute carrageenan-induced edema and the deleterious effects of chronic adjuvant-induced polyarthritis. Furthermore, these compounds were also able to induce a return toward a more normal phenotype in cancerous WB-Ras epithelial cells, via the interruption of the growth factor-stimulated pathway precipitated by Substance P. Finally, our modeling studies provide a structural basis for both the reaction and subsite stereospecificity of PAM toward its substrates, competitive inhibitors, and mechanism-based inactivators. |
author |
Foster, Michael Scott |
author_facet |
Foster, Michael Scott |
author_sort |
Foster, Michael Scott |
title |
Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
title_short |
Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
title_full |
Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
title_fullStr |
Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
title_full_unstemmed |
Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
title_sort |
design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation |
publisher |
Georgia Institute of Technology |
publishDate |
2010 |
url |
http://hdl.handle.net/1853/31816 |
work_keys_str_mv |
AT fostermichaelscott designsynthesiskineticanalysismolecularmodelingandpharmacologicalevaluationofnovelinhibitorsofpeptideamidation |
_version_ |
1716475239754366976 |